XML 59 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Common Stock (Tables)
9 Months Ended
Sep. 30, 2016
Equity [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
The following table provides a summary of the impact of our outstanding stock-based compensation plans on the results of operations for the periods presented:

 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2016
 
2015
 
2016
 
2015
 
 
(in thousands)
 
 
 
 
 
 
 
 
 
Stock-based compensation expense
 
$
4,079

 
$
4,813

 
$
15,205

 
$
14,278

Income tax benefit
 
(1,552
)
 
(1,828
)
 
(5,786
)
 
(5,423
)
Net stock-based compensation expense
 
$
2,527

 
$
2,985

 
$
9,419

 
$
8,855

 
 
 
 
 
 
 
 
 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
In January 2016, the Compensation Committee awarded 58,709 SARs to our executive officers. The fair value of each SAR award was estimated on the date of grant using a Black-Scholes pricing model using the following assumptions:

 
Nine Months Ended September 30,
 
2016
 
2015
 
 
 
 
Expected term of award
6.0 years

 
5.2 years

Risk-free interest rate
1.8
%
 
1.4
%
Expected volatility
54.5
%
 
58.0
%
Weighted-average grant date fair value per share
$
26.96

 
$
22.23

Schedule of Share-based Compensation, Stock Appreciation Rights Award Activity
The following table presents the changes in our SARs for all periods presented:
 
Nine Months Ended September 30,
 
2016
 
2015
 
Number of
SARs
 
Weighted-Average
Exercise
Price
 
Average Remaining Contractual
Term (in years)
 
Aggregate Intrinsic
Value
(in thousands)
 
Number of
SARs
 
Weighted-Average
Exercise
Price
 
Average Remaining Contractual
Term
(in years)
 
Aggregate Intrinsic
Value
(in thousands)
Outstanding beginning of year, January 1,
326,453

 
$
38.99

 
 
 
 
 
279,011

 
$
38.77

 
 
 
 
Awarded
58,709

 
51.63

 
 
 
 
 
68,274

 
39.63

 
 
 
 
Exercised
(141,084
)
 
40.16

 
 
 
$
2,770

 

 

 
 
 
 
Outstanding at September 30,
244,078

 
41.36

 
7.1
 
6,273

 
347,285

 
38.94

 
7.5
 
$
4,888

Vested and expected to vest at September 30,
238,671

 
41.20

 
7.1
 
6,171

 
341,423

 
38.89

 
7.5
 
4,821

Exercisable at September 30,
136,644

 
36.74

 
5.9
 
4,143

 
191,149

 
35.68

 
6.6
 
3,312

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table presents the changes in non-vested time-based awards to all employees, including executive officers, for the nine months ended September 30, 2016:
 
Shares
 
Weighted-Average
Grant Date
Fair Value
 
 
 
 
Non-vested at December 31, 2015
525,081

 
$
50.23

Granted
269,709

 
57.12

Vested
(256,976
)
 
48.60

Forfeited
(14,716
)
 
55.70

Non-vested at September 30, 2016
523,098

 
54.43

 
 
 
 

The following table presents the weighted-average grant date fair value per share and related information as of/for the periods presented:

 
As of/for the Nine Months Ended September 30,

 
2016
 
2015
 
(in thousands, except per share data)
 
 
 
 
Total intrinsic value of time-based awards vested
$
14,675

 
$
13,061

Total intrinsic value of time-based awards non-vested
35,079

 
30,959

Market price per common share as of September 30,
67.06

 
53.01

Weighted-average grant date fair value per share
57.12

 
48.58


Restricted Stock Awards, Market-Based, Valuation assumptions
In January 2016, the Compensation Committee awarded a total of 24,280 market-based restricted shares to our executive officers. In addition to continuous employment, the vesting of these shares is contingent on the Company's total shareholder return ("TSR"), which is essentially the Company’s stock price change including any dividends, as compared to the TSR of a group of peer companies. The shares are measured over a three-year period ending on December 31, 2018 and can result in a payout between 0% and 200% of the total shares awarded. The weighted-average grant date fair value per market-based share for these awards was computed using the Monte Carlo pricing model using the following assumptions:
 
Nine Months Ended September 30,
 
2016
 
2015
 
 
 
 
Expected term of award
3 years

 
3 years

Risk-free interest rate
1.2
%
 
0.9
%
Expected volatility
52.3
%
 
53.0
%
Weighted-average grant date fair value per share
$
72.54

 
$
66.16

Schedule of Nonvested Performance-based Units Activity
The following table presents the change in non-vested market-based awards during the nine months ended September 30, 2016:

 
 
Shares
 
Weighted-Average
Grant Date
Fair Value per Share
 
 
 
 
 
Non-vested at December 31, 2015
 
71,549

 
$
63.60

Granted
 
24,280

 
72.54

Vested (1)
 
(11,283
)
 
98.50

Non-vested at September 30, 2016
 
84,546

 
61.51

 
 
 
 
 
__________
(1)Vested shares were issued at 200% based on our relative total shareholder return as ranked among the Company's peer group.    



The following table presents the weighted-average grant date fair value per share and related information as of/for the periods presented:

 
As of/for the Nine Months Ended September 30,
 
2016
 
2015
 
(in thousands, except per share data)
 
 
 
 
Total intrinsic value of market-based awards vested
$
1,174

 
$

Total intrinsic value of market-based awards non-vested
5,670

 
5,996

Market price per common share as of September 30,
67.06

 
53.01

Weighted-average grant date fair value per share
72.54

 
66.16